טוען...
Quality of life in relapsing-remitting multiple sclerosis patients receiving CinnoVex compared with Avonex
OBJECTIVE: There is an increasing recognition among clinicians and researchers that the impact of chronic illnesses and their treatments must be assessed in terms of their quality of life (QoL) in addition to more traditional measures of clinical outcomes. The aim of this study was to compare the Qo...
שמור ב:
| הוצא לאור ב: | J Res Pharm Pract |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Medknow Publications & Media Pvt Ltd
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4966237/ https://ncbi.nlm.nih.gov/pubmed/27512709 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2279-042X.185725 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|